Hopital Saint-Joseph Service Oncologie

Site:	Hopital Saint-Joseph Service Oncologie
Address:
City:	Paris
State:
Zip:
Country:	France

Phase	Trial	Trial Status [asc]	Site Status	Drug	NCT#
2	Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations (AcSé)	Active, not recruiting	Closed	Vemurafenib	NCT02304809
3	A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment	Terminated	Active	Masitinib, (AB1010)	NCT00812240